3,4,5‑Trihydroxycinnamic acid suppresses phorbol‑12‑myristate‑13‑acetate and A23187‑induced mast cell activation in RBL‑2H3 cells

  • Authors:
    • Jin-Young Park
    • Hee Jae Lee
    • Eun-Taek Han
    • Jin-Hee Han
    • Won Sun Park
    • Yong-Soo Kwon
    • Wanjoo Chun
  • View Affiliations

  • Published online on: March 30, 2023     https://doi.org/10.3892/etm.2023.11926
  • Article Number: 227
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previously, anti‑inflammatory properties of 3,4,5‑Trihydroxycinnamic acid (THC) has been reported in lipopolysaccharide (LPS)‑induced RAW264.7 murine macrophage cells and in an LPS‑induced sepsis BALB/c mice animal model. However, the effect of THC on the anti‑allergic effect in mast cells has not been elucidated. The current study aimed to demonstrate the anti‑allergic properties of THC and its underlying mechanism. Rat basophilic leukemia (RBL‑2H3) cells were treated with phorbol‑12‑myristate‑13‑acetate (PMA) and A23187, a calcium ionophore, to be activated. The anti‑allergic effect of THC was determined by measuring cytokine and histamine release. Western blotting was conducted to determine mitogen‑activated protein kinases (MAPKs) activation and nuclear factor‑κB (NF‑κB) translocation. THC significantly suppressed PMA/A23187‑induced tumor necrosis factor α secretion and THC also significantly attenuated degranulation, releasing β‑hexosaminidase and histamine in concentration‑dependent manners. Furthermore, THC significantly attenuated PMA/A23187‑induced cyclooxygenase 2 expression and nuclear translocation of NF‑κB. THC significantly suppressed PMA/A23187‑induced increased phosphorylation of p38 mitogen‑activated protein kinase, phosphorylated (p‑)extracellular signal‑regulated kinase 1/2 and p‑c‑Jun N‑terminal kinase in RBL‑2H3 cells. Overall, the results demonstrated that THC exhibited anti‑allergic action by significantly attenuating degranulation of mast cells through the inhibition of MAPKs/NF‑κB signaling pathway in RBL‑2H3 cells.
View Figures
View References

Related Articles

Journal Cover

May-2023
Volume 25 Issue 5

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Park J, Lee H, Han E, Han J, Park WS, Kwon Y and Chun W: 3,4,5‑Trihydroxycinnamic acid suppresses phorbol‑12‑myristate‑13‑acetate and A23187‑induced mast cell activation in RBL‑2H3 cells. Exp Ther Med 25: 227, 2023
APA
Park, J., Lee, H., Han, E., Han, J., Park, W.S., Kwon, Y., & Chun, W. (2023). 3,4,5‑Trihydroxycinnamic acid suppresses phorbol‑12‑myristate‑13‑acetate and A23187‑induced mast cell activation in RBL‑2H3 cells. Experimental and Therapeutic Medicine, 25, 227. https://doi.org/10.3892/etm.2023.11926
MLA
Park, J., Lee, H., Han, E., Han, J., Park, W. S., Kwon, Y., Chun, W."3,4,5‑Trihydroxycinnamic acid suppresses phorbol‑12‑myristate‑13‑acetate and A23187‑induced mast cell activation in RBL‑2H3 cells". Experimental and Therapeutic Medicine 25.5 (2023): 227.
Chicago
Park, J., Lee, H., Han, E., Han, J., Park, W. S., Kwon, Y., Chun, W."3,4,5‑Trihydroxycinnamic acid suppresses phorbol‑12‑myristate‑13‑acetate and A23187‑induced mast cell activation in RBL‑2H3 cells". Experimental and Therapeutic Medicine 25, no. 5 (2023): 227. https://doi.org/10.3892/etm.2023.11926